Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mechanisms and implications of imatinib resistance mutations in BCR-ABL.

Mechanisms and implications of imatinib resistance mutations in BCR-ABL. Curr Opin Hematol. 2004 Jan; 11(1):35-43.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.